ENVALITH
株式会社AFC-HDアムスライフサイエンス logo

AFC-HD AMS Life Science Co.,Ltd

2927・Standard Market・Foods

株式会社AFC-HDアムスライフサイエンス logo
AFC-HD AMS Life Science Co.,Ltd2927
Reference Indicators

Market Cap

127¥100M

P/E (Forecast)

—

P/B

0.8x

Dividend Yield (Forecast)

5.04%

ROE

7.7%

EV/EBITDA

6.7x
Financial Summary
Unit: ¥M
Item
2022Aug 2022
2023Aug 2023
2024Aug 2024
2025Aug 2025
2026Aug 2026
Net Sales
22,99725,57930,18532,65534,324
Cost of Sales
14,41816,25619,69321,39322,402
Gross Profit
8,5789,32210,49111,26111,922
SG&A Expenses
7,5677,6868,5758,8519,466
Operating Income
1,0111,6361,9162,4092,455
Non-operating Income
436116190315278
Non-operating Expenses
10498185280343
Ordinary Income
1,3431,6541,9212,4432,390
Extraordinary Income
0476627132
Extraordinary Losses
10815577514453
Pre-tax Income
1,2351,5451,9102,2001,968
Income Taxes
497439665732768
Net Income
7351,1021,2521,4481,198
EBITDA
2,0172,6203,0013,8063,930
Gross Margin
37.3%36.4%34.8%34.5%34.7%
Operating Margin
4.4%6.4%6.3%7.4%7.2%
ROA
2.0%2.7%2.7%3.0%2.4%
ROE
6.1%8.6%9.3%10.0%7.7%
Segment Performance
Unit: ¥M
2025
SegmentNet SalesOperating IncomeOperating Margin
ヘルスケア事業18,9032,45213.0%
医薬品事業2,4712309.3%
百貨店事業4,614611.3%
飲食事業2,364-74-3.1%
不動産・建託事業2,662160.6%
その他1,637-210-12.8%